WFM
IDXX icon

Wilmington Funds Management’s Idexx Laboratories IDXX Stock Holding History

Wilmington Funds Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$252K Buy
+3,780
New +$240K 0.03% 595

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Wilmington Funds Management's IDXX Position: Q2 2014 in Review

Wilmington Funds Management opened a new position in Idexx Laboratories (IDXX) in Q2 2014: 3,780 shares worth $252K. The stake represents 0.03% of the portfolio and ranks #595 among its holdings.

306 funds tracked by Wall St. Rank hold IDXX as of Q2 2014.

  • Wilmington Funds Management held 3,780 shares of Idexx Laboratories worth $252K as of Q2 2014.
  • Idexx Laboratories was a new Wilmington Funds Management position in Q2 2014.
  • Idexx Laboratories made up 0.03% of Wilmington Funds Management's portfolio in Q2 2014, its #595 holding.
  • 306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.